Patents Assigned to GENOVAX S.R.L.
  • ANTI-TUMOR IMMUNOTHERAPY
    Publication number: 20110135692
    Abstract: The present invention relates to the use of telomerase-derived peptides for the treatment of any cancer patients, particularly for the treatment of patients with renal or prostate cancer.
    Type: Application
    Filed: June 16, 2009
    Publication date: June 9, 2011
    Applicant: GENOVAX S.R.L.
    Inventors: Gilberto Filaci, Francesco Indiveri, Paolo Traverso